Advertisement

Overexpression of C1-tetrahydrofolate synthase in fetal Down Syndrome brain

  • M. Fountoulakis
  • T. Gulesserian
  • G. Lubec
Part of the Journal of Neural Transmission Supplement 67 book series (NEURAL SUPPL, volume 67)

Summary

Trisomy 21, Down Syndrome, is the most common genetic cause of human mental retardation and results from non-disjunction of chromosome 21. Several reports have been linking folate metabolism to DS and indeed, chromosome 21 even encodes for a specific folate carrier. The availability of brain tissue along with the advent of proteomics enabled us to identify and quantify C1-tetrahydrofolate synthase (THF-S), a key element in folate metabolism in brain along with other enzymes involved in C1-metabolism.

Brains of controls and DS subjects at the 18th–19th week of gestation were homogenised and separated on 2 dimensional gel electrophoresis with subsequent in-gel digestion and mass spectrometrical identification and quantification with specific software.

THF-S was represented by three spots, possibly representing isoforms or posttranslational modifications. Two spots were significantly, about twofold, increased in fetal DS brain:

Controls [means ± SD: (spot 1) 2.55 ± 0.69; (spot 3) 1.39 ± 0.86] vs. Down syndrome [means ± SD: (spot 1) 4.25 ± 1.63; (spot 3) 4.43 ± 2.13].

These results were reproducible when THF-S levels were normalised versus the housekeeping protein actin and neuron specific enolase to compensate cell or neuronal loss.

C1-metabolism related enzymes ribose-phosphate pyrophosphokinase I, inositol monophosphate dehydrogenase, guanidine monophosphate synthease and S-adenosylmethionine synthase, gamma form, were comparable between groups.

Overexpression of this key enzyme in fetal DS brain at the early second trimester may indicate abnormal folate metabolism and may reflect folate deficiency. This may be of pathomechanistic relevance and thus extends and confirms the involvement of folate metabolism in trisomy 21.

Keywords

Down Syndrome Neuron Specific Enolase Folate Metabolism Maternal Risk Factor Assisted Laser Desorption Ionisation Mass 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Al-Gazali LI, Padmanabhan R, Melnyk S, Yi P, Pogribny IP, Pogribna M, Bakir M, Hamid ZA, Abdulrazzaq Y, Dawodu A, James SJ (2001) Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect. Am J Med Genet 103: 128–132PubMedCrossRefGoogle Scholar
  2. Alvarez L, Corrales F, Martin-Duce A, Mato JM (1993) Characterisation of a full-length cDNA encoding human liver S-adenosylmethionine synthetase: tissue-specific gene expression and mRNA levels in hepatopathies. Biochem J 293: 481–486PubMedGoogle Scholar
  3. Appling DR (1991) Compartmentation of folate-mediated one-carbon metabolism in eukaryotes. FASEB J 5: 2645–2651PubMedGoogle Scholar
  4. Appling DR, Rabinowitz (1985) Regulation of expression of the ADE3 gene for yeast C1-tetrahydrofolate synthase, a trifunctional enzyme involved in one-carbon metabolism. J Biol Chem 260: 1248–1256Google Scholar
  5. Berndt P, Hobohm U, Langen H (1999) Reliable automatic protein identification from matrix assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis 20: 3521–3526PubMedCrossRefGoogle Scholar
  6. Blount BC, Mack MM, Wehr CM, Macgregor JT, Hiatt RA, Wickremasinghe RG, Everson RB, Ames BN (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Sci USA 94: 3290–3295CrossRefGoogle Scholar
  7. Botto LD, Yang Q (2000) 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151: 862–877Google Scholar
  8. Bradford M (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254PubMedCrossRefGoogle Scholar
  9. Chadefaux-Vekemans B, Coude M, Muller F, Oury JF, Chabli A, Jais J, Kamoun P (2002) Methylenetetrahydrofolate reductase polymorphism in the etiology of Down syndrome. Pediatr Res 51: 766–767PubMedGoogle Scholar
  10. Duthie SJ (1999) Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55: 578–592PubMedCrossRefGoogle Scholar
  11. Epstein CJ (1995) Down Syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease 7th edn. McGraw Hill, New York, pp 749–794Google Scholar
  12. Fountoulakis M, Langen H (1997) Identification of proteins by matrix assisted laser desorption ionisation mass spectrometry following in-gel digestion in low salt, nonvotalie buffer and simplified peptide recovery. Anal Biochem 250: 153–156PubMedCrossRefGoogle Scholar
  13. Fowler BM, Giuliano AR, Piyathilake C, Nour M, Hatch K (1998) Hypomethylation in cervical tissue: is there a correlation with folate status. Cancer Epidemiol Biomarkers Prey 7: 901–906Google Scholar
  14. Hassold TJ, Burrage LC, Chan ER, Judis LM, Schwartz S, James SJ, Jacobs PA, Thomas NS (2001) Maternal folate polymorphisms and the etiology of human nondisjunction. Am J Hum Genet 69: 434–439PubMedCrossRefGoogle Scholar
  15. Hine RJ, James SJ (2000) Down syndrome and folic acid update. J Am Diet Assoc 100: 1004Google Scholar
  16. Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ, Pogribna M, Rozen R, James SJ (2000) Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 67: 623–630PubMedCrossRefGoogle Scholar
  17. Hunt PA, Lemaire-Adkins R (1998) Genetic control of mammalian female meiosis. Curr Top Dev Biol 37: 359–381PubMedCrossRefGoogle Scholar
  18. Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, Miller BJ, Henning SM, Swendseid ME (1998) Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr 128: 1204–1212PubMedGoogle Scholar
  19. James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW (1999) Abnormal folate metabolism and mutation in the methylenetetragydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70: 495–501PubMedGoogle Scholar
  20. Kitzmueller E, Greber S, Fountoulakis M, Lubec G (2001) Carbohydrate handling enzymes in fetal Down syndrome brain. J Neural Transm [Suppl] 61: 203–210Google Scholar
  21. Langen H, Roeder D, Juranville J, Fountoulakis M (1997) Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis 18: 2085–2090PubMedCrossRefGoogle Scholar
  22. MacGregor JT, Wehr C, Hiatt RA, Peters B, Tucker JD, Langlois RG, Jacob RA, Jensen RH, Yager JW, Shigenaga MK, Frei B, Eynon BP, Ames BN (1997) “Spontaneous” genetic damage in man: evaluation of interindividual variability, relationship among markers of damage, and influence of nutritional status. Mutat Res 377: 125–135Google Scholar
  23. O’Leary VB, Parle-McDermott A, Molloy AM, Kirke PN, Johnson Z, Conley M, Scott JM, Mills JL (2002) MTRR and MTHFR polymorphism: link to Down syndrome? Am J Med Genet 107: 151–155PubMedCrossRefGoogle Scholar
  24. Pasternack LB, Littlepage LE, Laude DA Jr, Appling DR (1996) 13C NMR analysis of the use of alternative donors to the tetrahydrofolate-dependent one-carbon pools in Saccharomyces cerevisae. Arch Biochem Biophys 326: 158–165Google Scholar
  25. Peeters M, Rethore MO, de Kermadec S, Lejeune J (1989) Correlation between the effects of rT3 and IMP dehydrogenase inhibitors on normal and trisomic 21 lymphocyte cultures. Ann Genet 32: 211–213Google Scholar
  26. Picton H, Briggs D, Gosden R (1998) The molecular basis of oocyte growth and development. Mol Cell Endocrinol 145: 27–37PubMedCrossRefGoogle Scholar
  27. Rosenblatt DS (1999) Folate and homocysteine metabolism and gene polymorphisms in the etiology of Down syndrome. Am J Clin Nutr 70: 429–430PubMedGoogle Scholar
  28. Shane B (1989) Polyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam Horm 45: 263–335PubMedCrossRefGoogle Scholar
  29. Smith G, Berg J (1976) Down’s Anomaly, 2nd edn. Churchill Livingstone, Edinburgh New YorkGoogle Scholar
  30. Titenko-Holland N, Jacob RA, Shang N, Balaraman A, Smith MT (1998) Micronuclei in lymphocytes and exfoliated buccal cells of postmenopausal women with dietary change in folate. Mutat Res 417: 101–114PubMedGoogle Scholar
  31. van der Put NM, van Straaten HW, Trijbels FJ, Blom HJ (2001) Folate, homocysteine and neural tube defects: an overview. Exp Biol Med 226: 243–270Google Scholar
  32. Wahls WP, Song JM, Smith GR (1993) Single-stranded DNA binding activity of Cltetrahydrofolate synthase enzymes. J Biol Chem 268: 23792–23798PubMedGoogle Scholar
  33. Xu GL, Bestor TH, Bourchis D, Hsieh CL, Tommerup N, Bugge M, Hulten M, Qu XY, Russo TT, Veigas-Pequignot E (1999) Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402: 187–191PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • M. Fountoulakis
    • 1
  • T. Gulesserian
    • 2
  • G. Lubec
    • 2
    • 3
  1. 1.Genomics and Proteomics TechnologiesHoffmann-La RocheBaselSwitzerland
  2. 2.Division Basic Research, Department of PediatricsUniversity of ViennaAustria
  3. 3.Department of PediatricsCChem, FRSC (UK), University of ViennaViennaAustria

Personalised recommendations